|
|
|
Volumn 322, Issue 7288, 2001, Pages 731-732
|
|
Undertreatment of heart failure has high cost to patients [4] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
SPIRONOLACTONE;
COST OF ILLNESS;
HEALTH SERVICE;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
LETTER;
MORBIDITY;
MORTALITY;
NURSING;
PATIENT COMPLIANCE;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PROGNOSIS;
PUBLIC HEALTH;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DIURETICS;
FAMILY PRACTICE;
HEART FAILURE, CONGESTIVE;
HUMANS;
SPIRONOLACTONE;
TREATMENT FAILURE;
|
|
EID: 0035941931
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|
